Variant report
Variant | nsv966365 |
---|---|
Chromosome Location | chr4:103853934-103867198 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:15)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:15 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr4:103854368-103854411 | LNCaP | prostate: | n/a | n/a |
2 | FOXA1 | chr4:103861442-103861685 | T-47D | breast: | n/a | n/a |
3 | MYC | chr4:103857012-103857094 | MCF-7 | breast: | n/a | n/a |
4 | POLR2A | chr4:103857050-103857107 | MCF-7 | breast: | n/a | n/a |
5 | POLR2A | chr4:103857149-103857238 | Gliobla | brain: | n/a | n/a |
6 | POLR2A | chr4:103857047-103857175 | A549 | lung: | n/a | n/a |
7 | POLR2A | chr4:103857041-103857051 | MCF-7 | breast: | n/a | n/a |
8 | POLR2A | chr4:103857071-103857117 | Gliobla | brain: | n/a | n/a |
9 | SIN3AK20 | chr4:103859180-103859367 | H1-hESC | embryonic stem cell: | n/a | n/a |
10 | SIX5 | chr4:103859542-103859743 | K562 | blood: | n/a | n/a |
11 | SIX5 | chr4:103861745-103861943 | K562 | blood: | n/a | n/a |
12 | SPI1 | chr4:103863539-103863775 | GM12891 | blood: | n/a | n/a |
13 | ZBTB33 | chr4:103857365-103857608 | K562 | blood: | n/a | n/a |
14 | ZBTB33 | chr4:103854006-103854140 | HepG2 | liver: | n/a | n/a |
15 | ZBTB33 | chr4:103854377-103854644 | K562 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
SLC9B1 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs188994518 | chr4:103854018-103854019 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs12501737 | chr4:103854043-103854044 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
3 | rs200867309 | chr4:103854063-103854064 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs566855991 | chr4:103854376-103854377 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs34727189 | chr4:103854378-103854379 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs3974618 | chr4:103854400-103854401 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs201860888 | chr4:103854403-103854404 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs79750148 | chr4:103854414-103854415 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs201300098 | chr4:103854432-103854433 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs3974617 | chr4:103854440-103854441 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs186358727 | chr4:103854452-103854453 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs558914656 | chr4:103854468-103854469 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs190996393 | chr4:103854485-103854486 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs3974616 | chr4:103854500-103854501 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs573604005 | chr4:103854507-103854508 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs3974615 | chr4:103854528-103854529 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs3960815 | chr4:103854576-103854577 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs181017491 | chr4:103854590-103854591 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs186371692 | chr4:103854593-103854594 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs368800726 | chr4:103856800-103856801 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs374351222 | chr4:103856829-103856830 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs534402339 | chr4:103856836-103856837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs74569787 | chr4:103856842-103856843 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs77828967 | chr4:103856851-103856852 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs542543578 | chr4:103856869-103856870 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs201612094 | chr4:103856872-103856873 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs199512821 | chr4:103856899-103856900 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs115661172 | chr4:103856939-103856940 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs572645767 | chr4:103856957-103856958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs75497833 | chr4:103856977-103856978 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs376834357 | chr4:103857000-103857001 | Enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
32 | rs34369472 | chr4:103857001-103857002 | ZNF genes & repeats Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
33 | rs370737984 | chr4:103857003-103857004 | ZNF genes & repeats Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
34 | rs201804494 | chr4:103857004-103857005 | ZNF genes & repeats Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
35 | rs6533037 | chr4:103857022-103857023 | ZNF genes & repeats Flanking Bivalent TSS/Enh | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
36 | rs538125464 | chr4:103857044-103857045 | ZNF genes & repeats Flanking Bivalent TSS/Enh | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs114034010 | chr4:103857063-103857064 | ZNF genes & repeats Flanking Bivalent TSS/Enh | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs531692339 | chr4:103857072-103857073 | ZNF genes & repeats Flanking Bivalent TSS/Enh | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs368947581 | chr4:103857100-103857101 | ZNF genes & repeats Flanking Bivalent TSS/Enh | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs370192675 | chr4:103857115-103857116 | ZNF genes & repeats Flanking Bivalent TSS/Enh | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs377502780 | chr4:103857144-103857145 | ZNF genes & repeats Flanking Bivalent TSS/Enh | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs555340768 | chr4:103857146-103857147 | ZNF genes & repeats Flanking Bivalent TSS/Enh | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs192356371 | chr4:103857147-103857148 | ZNF genes & repeats Flanking Bivalent TSS/Enh | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs374475974 | chr4:103857165-103857166 | ZNF genes & repeats Flanking Bivalent TSS/Enh | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs368566193 | chr4:103857185-103857186 | ZNF genes & repeats Flanking Bivalent TSS/Enh | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs577670780 | chr4:103857218-103857219 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs371117874 | chr4:103857228-103857229 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs565734938 | chr4:103857408-103857409 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs545163573 | chr4:103857443-103857444 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs575143492 | chr4:103857477-103857478 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 16573809 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Melanoma | 20688739 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myelofibrosis | 22110671 | CNVD |
myeloid cancer | 21057493 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:103856800-103857000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr4:103857000-103857200 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr4:103857000-103857200 | ZNF genes & repeats | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr4:103857000-103857200 | Flanking Bivalent TSS/Enh | iPS DF 6.9 Cell Line | embryonic stem cell |
5 | chr4:103857000-103857200 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr4:103859000-103859200 | Enhancers | H1 Cell Line | embryonic stem cell |
7 | chr4:103859000-103859200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr4:103859000-103859400 | Bivalent Enhancer | HUES64 Cell Line | embryonic stem cell |
9 | chr4:103859000-103859400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
10 | chr4:103859000-103859600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
11 | chr4:103859000-103859600 | Enhancers | HUES6 Cell Line | embryonic stem cell |